![Elizabeth Buck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 357 403 $ al 31/08/2026
Elizabeth Buck is the founder of Black Diamond Therapeutics, Inc. since 2014, holding the title of Chief Scientific Officer.
Former job at OSI Pharmaceuticals, Inc. from 2005 to 2013 as Assistant Director-Advanced Preclinical.
Former job at MetaStat, Inc. from 2013 to 2014 as Chief Scientific Officer-Therapeutics.
Education includes an undergraduate degree from the University of New Hampshire and a doctorate from Icahn School of Medicine at Mount Sinai.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/01/2026 | 170.192 ( 0,3 % ) | 357 403 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Fundador | 01/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
| METASTAT, INC. | Director Técnico/Científico/I+D | 01/12/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaStat, Inc.
 MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
